Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-23-000031
Filing Date
2023-05-11
Accepted
2023-05-11 15:29:30
Documents
4
Period of Report
2023-05-11

Document Format Files

Seq Description Document Type Size
1 6-K a2023agmresultsform6-k.htm 6-K 19573
2 EX-99.1 oncolyticsvotingresults.htm EX-99.1 41690
3 kristinesigna.jpg GRAPHIC 2777
4 odettesigna.jpg GRAPHIC 3287
  Complete submission text file 0001129928-23-000031.txt   70812
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 23910595
SIC: 2834 Pharmaceutical Preparations